Exact Sciences

Eradicating cancer starts with supporting each person and community affected by cancer. This #WorldCancerDay, we recognize the diverse stories and unique experiences behind every diagnosis and stand together in the fight against this disease. Learn how you can help take action: http://spr.ly/6046hyZng #UnitedByUnique

We applaud Congress on the passage of the #MCEDAct. This landmark legislation establishes a Medicare coverage pathway for MCED tests, such as the Cancerguard® test, potentially expanding access to innovative early cancer-detection technologies. Read more: http://spr.ly/6047hHxRZ

We're celebrating a meaningful milestone ahead of #WorldCancerDay: more than 2 million breast cancer patients worldwide have received personalized care with the Oncotype DX Breast Recurrence Score® test. This means 2 million patients and health care providers were empowered to make confident, informed treatment decisions — guidance that can be life-changing. Every test tells a unique story, and we’re proud to celebrate every patient, provider, and team member who has been part of more than 2 million of them. http://spr.ly/6040hH9F6 #OncotypeDX2Million

Randy’s life has been full of adventure. A school teacher in the Peace Corps, a fantasy author, a world traveler, and a proud husband and father, he lived his life to the fullest. Until November 2024, when a late-stage pancreatic cancer diagnosis interrupted that life of magic: “They told me I likely had about 15 months left.” Randy Webster passed away on January 24th, 2026. But his legacy continues. By sharing his story, he hopes for a future where cancers like his are caught earlier – giving families more time, more memories, and more magic together. And with the Cancerguard® test, that future could become reality. Read more: http://spr.ly/6045hEwxc Katie Couric Media

🗣️ Early cancer detection changes lives. Colorectal cancer has become the #1 cancer killer in adults under the age of 50, and colorectal cancer rates have been increasing in younger adults for decades. If you are 45 years or older, it’s time to get screened.

A new publication in JAMA reveals colorectal cancer is now the #1 cancer killer for people under 50 years. That means early detection and getting screened starting at age 45 is more important than ever. When colorectal cancer is detected early, it may be more treatable, leading to better outcomes. Learn more: http://spr.ly/6045C7EmL

Today we honor Dr. Martin Luther King Jr., whose life and legacy continue to inspire action towards equality and justice for all. http://spr.ly/6048CqBzG

We heard 2026 is the new 2016, and even though a lot has changed over the last 10 years, our commitment to eradicating cancer remains the same.

Proud to share new insights at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. We're presenting two abstracts that demonstrate how machine learning and claims data can unlock scalable, real-world insights for cancers such as liver and pancreatic, supporting innovative early detection strategies. #GI26

As the licensee of Freenome’s CRC blood tests, Exact Sciences is excited to see this new data from Freenome at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Improving early-stage and precancer detection on CRC blood tests is crucial to ensure the best outcomes for patients who won’t use other screening options. We’re excited to have these blood tests as part of our portfolio, so patients will be able to access the test that’s right for them. #GI26